PREGNABIT – the world’s first complex telemedical mobile CTG system for pregnancy examination

Informacje na temat projektu

PREGNABIT

Identyfikator umowy o grant: 761945

DOI

10.3030/761945

Projekt został zamknięty

Data podpisania przez KE 4 Lutego 2017

Data rozpoczęcia 1 Lutego 2017

Data zakończenia 30 Kwietnia 2017

Finansowanie w ramach

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Koszt całkowity

€ 71 429,00

Wkład UE

€ 50 000,00

Koordynowany przez

NESTMEDIC SPOLKA Z OGRANICZONA ODPWIEDZIALNOSCIA
Poland

Periodic Reporting for period 1 - PREGNABIT (PREGNABIT – the world’s first complex telemedical mobile CTG system for pregnancy examination)

Okres sprawozdawczy: 2017-02-01 do 2017-04-30

Podsumowanie kontekstu i ogólnych celów projektu

Pregnabit is a small portable medical device, which measures the heart rate of both mother and baby, uterine contractions and tracks foetal movements. In contrast to conventional CTG, Pregnabit can be used in safe home environment without a need to traveling to the hospital.
Pregnabit device is part of the complex telemedical system. All the data collected by Pregnabit are transferred to Medical Telemonitoring Centre. Results are immediately checked by a professional gynaecologist who verify the data before sending feedback to the pregnant. Results of every test are available for both the pregnant and her doctor/midwife on the safe web portal.
The Pregnabit device is a registered medical device (CE marking) for home CTG testing, available on Polish market. The supporting Medical Telemonitoring Centre is currently working in Poland.
The goal of the Feasibility Study was to evaluate the legal, economic and technical viability of introducing Pregnabit on European markets, Spain and France in the first instance.

Prace wykonane od początku projektu do końca okresu sprawozdawczego oraz najważniejsze dotychczasowe rezultaty

Regulations corresponding to medical devices class II and telemedicine has been studied in Spain and France. Procedures for running the services have been prepared and key partnerships with telemedicine service providers have been established.
The updated system architecture, including integration with service providers in targeted countries, has been prepared. The market sizing and segmentation has been evaluated. The total investment required to run the service in targeted countries has been also calculated.
The final recommendation from the conducted Feasibility Study is to launch the Phase 2 of the project, which will comprise telemedical service deployment in Spain and France.

Innowacyjność oraz oczekiwany potencjalny wpływ (w tym dotychczasowe znaczenie społeczno-gospodarcze i szersze implikacje społeczne projektu)

The outcome of the project will be a Telemedical CTG service running 24/7 in selected EU countries. Our solution will provide the expecting mothers with immediate information about their baby’s health, and if the medical intervention is necessary, the doctor will be immediately informed. The overall impact of the project will be safer mother and their baby for a lower cost to the healthcare system.

Pregnabit device with sensors.